BioCardia, Inc. CEO to Present at H.C. Wainwright 2026 Conference

What Happened BioCardia, Inc. filed a Form 8-K on September 10, 2026 (Item 8.01) to announce that President and CEO Peter Altman, Ph.D., will present at the H.C. Wainwright 28th Annual Global Investment Conference. The conference takes place September 14–16, 2026, at the Lotte New York Palace Hotel in New York City. The company issued a press release about the presentation, which was furnished as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: September 10, 2026 (Form 8-K, Item 8.01 — Other Events).
• Presenter: Peter Altman, Ph.D., President and Chief Executive Officer of BioCardia.
• Event: H.C. Wainwright 28th Annual Global Investment Conference, September 14–16, 2026.
• Location: Lotte New York Palace Hotel, New York City; press release attached as Exhibit 99.1.

Why It Matters Investor conferences give management a platform to update analysts, investors and potential partners on strategy, milestones and progress. While this 8-K does not include new financial results or operational disclosures, the presentation could provide material updates or clarification on BioCardia’s programs; investors should watch for the presentation content or any follow-up disclosures.